Brief: Biocept Determines Co's Interim Financial Statements Can No Longer Be Relied Upon - SEC Filing

Biocept

31/01/2022 12:37

Jan 31 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT-  ON JAN 25, DETERMINED THAT CO'S INTERIM
FINANCIAL
STATEMENTS FOR 3 AND 9 MONTHS ENDED SEPT 30, 2021 CAN NO LONGER
BE RELIED UPON - SEC FILING
    * BIOCEPT - DISCOVERED THAT CO FAILED TO ACCRUE FOR CERTAIN
EXPENSES INCURRED DURING Q3 IN AMOUNT ESTIMATED TO BE ABOUT $1.0
MILLION TO $1.2 MILLION
    * BIOCEPT- PLANS TO RESTATE RELEVANT FINANCIAL STATEMENTS AS
SOON
AS REASONABLY PRACTICABLE IN AN AMENDMENT TO ITS FORM 10-Q FOR
QUARTER-ENDED SEPT 30, 2021

Source text for Eikon:  ID: 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))